Back
Larimar Therapeutics Stock Price Chart
Sponsored
LRMR
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Buy
58
LRMR
Larimar Therapeutics
Last Price:
6.45
Seasonality Move:
-19.78%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight buying pressure.
Larimar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.51 | Sell |
20-day SMA: | 6.96 | Sell |
50-day SMA: | 8.86 | Sell |
200-day SMA: | 5.22 | Buy |
8-day EMA: | 6.55 | Sell |
20-day EMA: | 7.01 | Sell |
50-day EMA: | 7.49 | Sell |
200-day EMA: | 5.97 | Buy |
Larimar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 36.74 | Sell |
Chaikin Money Flow: | 14300 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.6 - 7.54) | Sell |
Bollinger Bands (100): | (4.24 - 9.58) | Sell |
Larimar Therapeutics Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Larimar Therapeutics Stock
Is Larimar Therapeutics Stock a Buy?
- Larimar Therapeutics share price is 6.44 while LRMR 8-day simple moving average is 6.51, which is a Sell signal.
- The stock price of LRMR is 6.44 while Larimar Therapeutics 20-day SMA is 6.96, which makes it a Sell.
- Larimar Therapeutics 50-day simple moving average is 8.86 while LRMR share price is 6.44, making it a Sell technically.
- LRMR stock price is 6.44 and Larimar Therapeutics 200-day simple moving average is 5.22, creating a Buy signal.
LRMR Technical Analysis vs Fundamental Analysis
Buy
58
Larimar Therapeutics (LRMR)
is a Buy
Is Larimar Therapeutics a Buy or a Sell?
-
Larimar Therapeutics stock is rated a Buy
The current Larimar Therapeutics [LRMR] share price is $6.44. The Score for LRMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Larimar Therapeutics Stock Info
Market Cap:
410.87M
Price in USD:
6.44
Share Volume:
128.7K
Larimar Therapeutics 52-Week Range
52-Week High:
13.68
52-Week Low:
2.18
Buy
58
Larimar Therapeutics (LRMR)
is a Buy
Larimar Therapeutics Share Price Forecast
-
What is the Larimar Therapeutics stock price today?
The Larimar Therapeutics stock price is 6.44 USD today. -
Will LRMR stock go up or go down?
Larimar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Larimar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Larimar Therapeutics is not overvalued.
Is Larimar Therapeutics Stock a Buy?
- Larimar Therapeutics share price is 6.44 while LRMR 8-day exponential moving average is 6.55, which is a Sell signal.
- The stock price of LRMR is 6.44 while Larimar Therapeutics 20-day EMA is 7.01, which makes it a Sell.
- Larimar Therapeutics 50-day exponential moving average is 7.49 while LRMR share price is 6.44, making it a Sell technically.
- LRMR stock price is 6.44 and Larimar Therapeutics 200-day simple moving average is 5.97, creating a Buy signal.
Fundamental Analysis of Larimar Therapeutics
Is Larimar Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Larimar Therapeutics
Should I short Larimar Therapeutics stock?
- LRMR Moving Average Covergence Divergence (MACD) indicator is -0.52, suggesting Larimar Therapeutics is a Sell
- Larimar Therapeutics Relative Strength Index (RSI) is 36.74, which suggest Larimar Therapeutics is oversold
- The Bollinger Bands (25) for Larimar Therapeutics is (6.6 - 7.54), which suggest Larimar Therapeutics is a Sell
- The Bollinger Bands (100) for Larimar Therapeutics is (4.24 - 9.58), which suggest Larimar Therapeutics is a Sell
* Larimar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.